10A N.C. Admin. Code 42B .0107 - NEWBORN SCREENING FOR POMPE DISEASE, MPS-1, AND X-ALD
Pompe disease, Mucopolysaccharidosis Type I (MPS I), and X-Linked Adrenoleukodystrophy (X-ALD) are added to the Newborn Screening Program. The process to develop and implement new tests for these conditions shall begin after the fee is established and adequate funds exist to acquire instrumentation, equipment, Program supplies, Program personnel, perform assay validations, implement preventative follow-up interventions, secure necessary infrastructure, and with the assurance that the laboratory has met all federal, State, and local requirements.
Notes
Eff. September 1, 2018.
Eff. September 1, 2018.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.